- Home
- STRO vs OFS Comparison
STRO vs OFS Comparison
Compare STRO & OFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- OFS
- Stock Information
- Founded
- STRO 2003
- OFS 2001
- Country
- STRO United States
- OFS United States
- Employees
- STRO N/A
- OFS N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- OFS Finance/Investors Services
- Sector
- STRO Health Care
- OFS Finance
- Exchange
- STRO Nasdaq
- OFS Nasdaq
- Market Cap
- STRO 94.9M
- OFS 95.6M
- IPO Year
- STRO 2018
- OFS 2012
- Fundamental
- Price
- STRO $0.95
- OFS $5.17
- Analyst Decision
- STRO Hold
- OFS
- Analyst Count
- STRO 7
- OFS 0
- Target Price
- STRO $1.97
- OFS N/A
- AVG Volume (30 Days)
- STRO 1.6M
- OFS 106.8K
- Earning Date
- STRO 11-10-2025
- OFS 10-30-2025
- Dividend Yield
- STRO N/A
- OFS 13.23%
- EPS Growth
- STRO N/A
- OFS N/A
- EPS
- STRO N/A
- OFS 0.24
- Revenue
- STRO $104,473,000.00
- OFS $42,970,000.00
- Revenue This Year
- STRO $65.48
- OFS N/A
- Revenue Next Year
- STRO N/A
- OFS N/A
- P/E Ratio
- STRO N/A
- OFS $21.32
- Revenue Growth
- STRO N/A
- OFS N/A
- 52 Week Low
- STRO $0.52
- OFS $5.10
- 52 Week High
- STRO $4.60
- OFS $9.80
- Technical
- Relative Strength Index (RSI)
- STRO 45.59
- OFS 19.43
- Support Level
- STRO $1.01
- OFS $5.25
- Resistance Level
- STRO $1.20
- OFS $5.45
- Average True Range (ATR)
- STRO 0.12
- OFS 0.32
- MACD
- STRO -0.02
- OFS -0.17
- Stochastic Oscillator
- STRO 8.09
- OFS 6.07
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About OFS OFS Capital Corporation
OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its business objective is to generate current income and capital appreciation by investing in middle-market companies in the United States. The company focuses on investments in senior secured loans, including first lien, second lien, and unitranche loans, as well as subordinated loans and, to a lesser extent, warrants, and other equity securities.